Hematologic Malignancies
📧 Sign up to get email alerts when something new happens for Hematologic Malignancies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: The Effect of Exercise and Nicotinamide Riboside Muscle Health and Insulin Resistance in Survivors of Childhood Cancer [NA]
This clinical trial update describes a study evaluating the effects of exercise and nicotinamide riboside on muscle health and insulin resis…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method
This clinical trial update from MD Anderson outlines a study to formulate expert consensus cancer care guidelines using the Delphi method; t…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: A Study of Haploidentical Bone Marrow Transplant for Patients With Hematologic Malignancies [Phase 2]
Phase 2 study of haploidentical bone marrow transplantation for hematologic malignancies was terminated, with results posted on 2025-11-10.
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Remote Monitoring in Cancer Care: A Platform Study
Completed results of a Mayo Clinic platform study evaluating remote monitoring in cancer care across head and neck cancer, hematologic malig…
-
CLINICAL_TRIALS research · 2025-10-23Clinical Trial Update: Parental Attitudes and Beliefs Regarding Risks Associated With Opioid Use in Children With Cancer
An ongoing MD Anderson Cancer Center study investigates parental attitudes toward opioid risks in pediatric cancer patients; the trial is cu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease [Phase 1]
GRAVITAS-119, a Phase 1 study evaluating itacitinib with calcineurin inhibitor-based interventions for prophylaxis of graft-versus-host dise…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes [Phase 1]
Phase 1 pharmacokinetic study update characterizes belinostat exposure across patients with different UGT1A1*28 genotypes (wild-type, hetero…
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
St. Jude Children's Research Hospital is conducting a prospective study to perform next-generation sequencing on normal tissues in pediatric…
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: A Second Psilocybin Group Therapy for the Treatment of Cancer-Related Anxiety in Partial Responders With Metastatic Cancer [Phase 1]
Phase 1 trial update examining second psilocybin-assisted group therapy for cancer-related anxiety in partial responders with metastatic can…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Enhanced, EHR-facilitated Cancer Symptom Control Pragmatic Clinical Trial [NA]
A completed pragmatic clinical trial at Mayo Clinic evaluating enhanced, electronic health record–facilitated cancer symptom control; result…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies. [Phase 2]
Phase 2 pediatric trial evaluating GVHD prophylaxis without calcineurin inhibitors after day 60 post first allogeneic hematopoietic stem cel…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials [NA]
Clinical trial update from Institut Bergonié describes profiling patients with cancer to match molecular alterations with experimental drugs…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: A Study of GNC-035 in Relapsed or Refractory Non-Hodgkin 's Lymphoma and Other Hematological Malignancies [Phase 1, Phase 2]
This clinical trial listing indicates that GNC-035 is being studied in relapsed or refractory non-Hodgkin lymphoma and other hematologic mal…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Analyse of Tumour and Constitutional DNA for the Study of the Determinism in Child Neoplasia [NA]
Clinical trial update describing analyses of tumor and germline DNA to study determinants of cancer in children; focuses on pediatric tumors…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Positive Activities Intervention to Improve Quality of Life in Collectivist Culture Cancer Patients and Their Caregivers [NA]
Clinical trial assessing a positive activities intervention to improve quality of life for cancer patients and their caregivers in collectiv…
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Survivorship Post-HCT Optimization Program [NA]
Clinical trial update reports the completion of Duke University’s Survivorship Post-HCT Optimization Program trial. The study targets patien…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Reduced Post-transplant Cyclophosphamide Dose in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies [Phase 3]
This Phase 3 trial assesses a reduced dose of post-transplant cyclophosphamide in patients undergoing haploidentical hematopoietic stem cell…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Study of SUPLEXA in Patients With Metastatic Solid Tumours and Haematologic Malignancies [Phase 1]
Phase 1 study of SUPLEXA in patients with metastatic solid tumors and hematologic malignancies has completed with results posted.
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
NCI-sponsored prospective study aims to procure tumor tissue to identify novel therapeutic targets and study the tumor microenvironment; enr…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy.
A completed clinical trial update examining predictive biomarkers for response and toxicity in patients with hematologic malignancies treate…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia
This entry notes the completion of a clinical trial focused on collecting peripheral blood from patients with hematologic malignancies and t…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Virtual Reality Intervention for Symptom Management in Stem Cell Transplantation [NA]
A clinical trial update describes a virtual reality intervention to assist symptom management in patients undergoing hematopoietic stem cell…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic Anemia [Phase 1]
Phase 1 study evaluating T cell-depleted allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in patients …
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies
This document describes a long-term follow-up study involving subjects who received CRISPR-based CAR T cell therapies; the trial is currentl…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: 18F-Pentixafor PET in Hematologic Malignancies
This entry reports an ongoing clinical trial evaluating 18F-Pentixafor PET imaging in hematologic malignancies, currently recruiting partici…